Max Financial Services (MFSL) Q4 05/06 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 05/06 earnings summary
23 Oct, 2026Executive summary
Consolidated total income rose to Rs 153,893.73 lakh from Rs 69,978.61 lakh; net profit was Rs 31,310.24 lakh after a prior-year net loss, with a Rs 42,763 lakh Hutchison Essar disposal gain contributing materially.
Life insurance and healthcare expanded rapidly; specialty products remained profitable, while healthcare, staffing and clinical research continued to require investment.
Financial highlights
Consolidated PBT was Rs 33,526.16 lakh versus a loss of Rs 15,656.34 lakh; net profit was Rs 31,310.24 lakh versus a net loss of Rs 11,672.48 lakh.
Consolidated basic EPS was Rs 93.52 and diluted EPS Rs 89.08; the prior-year basic and diluted EPS were both negative Rs 48.44.
Standalone total income was Rs 148.85 crore and net profit Rs 5.89 crore; PBT was Rs 3.52 crore versus Rs 6.45 crore in FY04/05.
Standalone prior-year PAT included a Rs 5.50 crore exceptional item; FY05/06 net profit was Rs 5.89 crore.
Outlook and guidance
Life insurance growth was expected to remain strong, with private-sector industry growth forecast at 59% CAGR over five years and private market share expected to reach 45% by 2010.
Healthcare plans included ramping the Saket tertiary hospital and opening a 100-bed Gurgaon facility, expected by June 2007; total beds were projected to reach over 1,600 by 2008.
A 20,000 TPA specialty-products line was planned to become operational in Q2 2007; a third metalliser was expected in October 2006, with metallising capacity targeted to triple by mid-2007.
Healthcare staffing planned two additional sourcing and training centres; placement revenue was expected to accelerate as more candidates became billable.
Latest events from Max Financial Services
- Standalone profit growth and core-business expansion contrasted with a Rs 154.39 crore consolidated loss.MFSL
Q4 01/02 - Post-merger profit reached Rs. 180.62 lakhs as expansion plans met execution and licensing risks.MFSL
Q4 92/93 - FY95 profit rose as business units expanded and telecom ventures launched, alongside sizable commitments and exposures.MFSL
Q4 94/95 - FY94 profit reached Rs 775.53 lakh as pharma and BOPP growth strengthened operations.MFSL
Q4 93/94 - Revenue rose as investment-backed expansion broadened the business portfolio.MFSL
Q4 95/96 - Combined business volume grew, but lower profit and market pressures tempered FY97.MFSL
Q4 96/97 - Service-sector expansion advanced as lower investment income sharply reduced parent-level profit.MFSL
Q4 00/01 - Rs 37.20 crore PAT backed a pivot to healthcare, insurance and IT.MFSL
Q4 99/00 - A one-time telecom dividend lifted earnings as operating units improved and growth plans shifted to services.MFSL
Q4 98/99